A phase II trial testing the thermal dose parameter CEM43° T90 as a predictor of response in soft tissue sarcomas treated with pre-operative thermoradiotherapy

Author: Maguire P. D.   Samulski T. V.   Prosnitz L. R.   Jones E. L.   Rosner G. L.   Powers B.   Layfield L. W.   Brizel D. M.   Scully S. P.   Harrelson J. M.   Dewhirst M. W.  

Publisher: Informa Healthcare

ISSN: 1464-5157

Source: International Journal of Hyperthermia, Vol.17, Iss.4, 2001-07, pp. : 283-290

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content